TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 23519697

Group type: EXPERIMENTAL
Intervention: Flywheel exercise 2-3 times per week
Number of subjects: 25

Group type: COMPARATOR
Intervention: Control group (no exercise)
Number of subjects: 25
Study: 20399023

Group type: EXPERIMENTAL
Intervention: Alcohol
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Placebo
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Condom use
Number of subjects: 200
Study: 18422390

Group type: EXPERIMENTAL
Intervention: Niacin extended release and simvastatin (NER/S) 2,000/40 mg/day
Number of subjects: 520
Study: 16052221

Group type: EXPERIMENTAL
Intervention: Contralateral prophylactic mastectomy (CPM)
Number of subjects: 148

Group type: COMPARATOR
Intervention: Surveillance
Number of subjects: 148
Study: 14578234

Group type: COMPARATOR
Intervention: Normal Glucose Tolerance (NGT)
Number of subjects: 595

Group type: EXPERIMENTAL
Intervention: Impaired Glucose Tolerance (IGT)
Number of subjects: 595

Group type: EXPERIMENTAL
Intervention: Baseline factors associated with worsening glucose tolerance
Number of subjects: 595

Group type: EXPERIMENTAL
Intervention: IGT reverting to NGT
Number of subjects: 595

Group type: EXPERIMENTAL
Intervention: Serum triglyceride, HDL cholesterol, and insulin resistance values in 2000
Number of subjects: 595

Group type: EXPERIMENTAL
Intervention: CVD risk factors associated with IGT
Number of subjects: 595
Study: 10579264

Group type: EXPERIMENTAL
Intervention: Lorazepam
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Midazolam
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 30
Study: 8920701

Group type: EXPERIMENTAL
Intervention: Bio-Hep-B (2.5 micrograms)
Number of subjects: 217

Group type: COMPARATOR
Intervention: Engerix-B (10 micrograms)
Number of subjects: 217
Study: 1986529

Group type: EXPERIMENTAL
Intervention: Counterrotational power toothbrush
Number of subjects: 20

Group type: COMPARATOR
Intervention: Manual toothbrush
Number of subjects: 20
Study: 29662130

Group type: EXPERIMENTAL
Intervention: Educational intervention in intervention communities (n=12)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Usual care in control communities (n=12)
Number of subjects: 200
Study: 29855986

Group type: EXPERIMENTAL
Intervention: Ginkgo biloba extract EGb 761, 120 mg twice a day
Number of subjects: 197

Group type: COMPARATOR
Intervention: Pentoxifylline, 600 mg twice a day
Number of subjects: 197
Study: 26892690

Group type: EXPERIMENTAL
Intervention: Laparoscopic radiofrequency volumetric thermal ablation (RFVTA)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Laparoscopic myomectomy
Number of subjects: 51
Study: 24908429

Group type: EXPERIMENTAL
Intervention: Early and intensive nutrition intervention (NI) delivered over the telephone/face‐to‐face
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Early and intensive nutrition intervention (NI)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Standard nutrition care (SC)
Number of subjects: 21
Study: 22369095

Group type: EXPERIMENTAL
Intervention: Methadone
Number of subjects: 16

Group type: COMPARATOR
Intervention: Buprenorphine
Number of subjects: 16
Study: 18285398

Group type: EXPERIMENTAL
Intervention: Adenosine 100 microg/kg/min
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study: 17760655

Group type: EXPERIMENTAL
Intervention: Pantoprazole 40 mg once daily
Number of subjects: 254

Group type: EXPERIMENTAL
Intervention: Nizatidine 150 mg twice daily
Number of subjects: 254

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 254
Study: 16398426

Group type: EXPERIMENTAL
Intervention: Traditional herbal medicine (CM) therapy
Number of subjects: 413

Group type: COMPARATOR
Intervention: Western medicine (WM) therapy
Number of subjects: 413
Study: 12173961

Group type: EXPERIMENTAL
Intervention: Massage using The Stick
Number of subjects: 30

Group type: COMPARATOR
Intervention: Visualization (control)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Mock insensible electrical stimulation (placebo)
Number of subjects: 30
Study: 9690725

Group type: EXPERIMENTAL
Intervention: Omeprazole 20 mg o.m. for 4-8 weeks
Number of subjects: 98

Group type: COMPARATOR
Intervention: Sucralfate 2 g b.d. for 4-8 weeks
Number of subjects: 98
Study: 8594677

Group type: EXPERIMENTAL
Intervention: Maloprim (pyrimethamine plus dapsone)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 2564901

Group type: EXPERIMENTAL
Intervention: Untreated patients with newly diagnosed prostate cancer
Number of subjects: 223

Group type: COMPARATOR
Intervention: Poorly differentiated tumours
Number of subjects: 223
Study: 581421

Group type: EXPERIMENTAL
Intervention: Oral antibacterial preparation with phthalylsulfathiazole and neomycin
Number of subjects: 290

Group type: EXPERIMENTAL
Intervention: Oral antibacterial preparation with phthalylsulfathiazole, neomycin, and tetracycline
Number of subjects: 290

Group type: COMPARATOR
Intervention: No antibacterial preparation
Number of subjects: 290
Study: 31922333

Group type: EXPERIMENTAL
Intervention: RARC
Number of subjects: 298

Group type: COMPARATOR
Intervention: LRC
Number of subjects: 298
Study: 31432438

Group type: EXPERIMENTAL
Intervention: CHOICE care management intervention
Number of subjects: 304

Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 304
Study: 28765494

Group type: EXPERIMENTAL
Intervention: EPAP with 10 cm H2O (EPAP10)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: EPAP with 5 cm H2O (EPAP5)
Number of subjects: 15

Group type: COMPARATOR
Intervention: No EPAP
Number of subjects: 15
Study: 25873295

Group type: EXPERIMENTAL
Intervention: Mind-Body Bridging (MBB)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Mindfulness Meditation (MM)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Sleep Hygiene Education (SHE)
Number of subjects: 30
Study: 24039409

Group type: EXPERIMENTAL
Intervention: Oral supplementation with omega-3 fatty acids (1.5 grams per day)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Placebo oral agent
Number of subjects: 61
Study: 20572888

Group type: EXPERIMENTAL
Intervention: Urea 2% cream (GEHWOL FUSSKRAFT blau)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Petrolatum containing cream (GEHWOL med Schrundensalbe)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Urea 10% cream (GEHWOL med Lipidro‐Crème)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Urea 10% foam (Allpresan Fuss Schaum)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Vaseline (positive control)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Untreated area on the volar forearms
Number of subjects: 0
Study: 19895185

Group type: EXPERIMENTAL
Intervention: Electronic asthma monitoring system (AMS)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Paper diary
Number of subjects: 59
Study: 17122719

Group type: EXPERIMENTAL
Intervention: Radical Prostatectomy (RP) recommendation for black patients with high social vulnerability
Number of subjects: 1313

Group type: EXPERIMENTAL
Intervention: Radical Prostatectomy (RP) recommendation for white patients with high social vulnerability
Number of subjects: 1313
Study: 15583533

Group type: EXPERIMENTAL
Intervention: 50% nitrous oxide preoperatively for 20 minutes
Number of subjects: 36

Group type: COMPARATOR
Intervention: 100% oxygen preoperatively for 20 minutes (control)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: 50% nitrous oxide postoperatively for 20 minutes
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: 5-point categorical patient global assessment scale
Number of subjects: 36
Study: 11736884

Group type: EXPERIMENTAL
Intervention: Oral tropisetron (5 mg)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Intravenous tropisetron (2 mg)
Number of subjects: 18
Study: 9406126

Group type: EXPERIMENTAL
Intervention: GLN-enriched TPN (GT)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Standard TPN (ST)
Number of subjects: 20
Study: 8503942

Group type: EXPERIMENTAL
Intervention: Coenzyme Q10 and vitamin B6 (pyridoxine) administered together
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Coenzyme Q10 administered alone
Number of subjects: 3

Group type: COMPARATOR
Intervention: Vitamin B6 (pyridoxine) administered alone
Number of subjects: 3
Study: 2449724

Group type: EXPERIMENTAL
Intervention: Transurethral prostatectomy (TURP)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Transurethral incision of the prostate (TUI)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Both surgical procedures (TURP and TUI)
Number of subjects: 21
Study: 30729863

Group type: EXPERIMENTAL
Intervention: Agentic narcissism
Number of subjects: 474

Group type: EXPERIMENTAL
Intervention: Communal narcissism
Number of subjects: 474

Group type: COMPARATOR
Intervention: Non-narcissists
Number of subjects: 474
Study: 29178564

Group type: EXPERIMENTAL
Intervention: UC-MSC infusion (1 × 10^6 /kg body weight)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: UC-MSC infusion
Number of subjects: 27

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 27
Study: 25381588

Group type: EXPERIMENTAL
Intervention: Single-site laparoscopic surgery (SSLS) using conventional laparoscopic (CL) instruments
Number of subjects: 60

Group type: COMPARATOR
Intervention: 3-port conventional laparoscopic (CL) appendectomy
Number of subjects: 60
Study: 23820246

Group type: EXPERIMENTAL
Intervention: LP299v
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo (inactivated LP299v)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Water
Number of subjects: 25
Study: 20406393

Group type: EXPERIMENTAL
Intervention: Fluconazole
Number of subjects: 283

Group type: EXPERIMENTAL
Intervention: Nystatin
Number of subjects: 283

Group type: COMPARATOR
Intervention: Fluconazole (susceptible isolates)
Number of subjects: 283

Group type: COMPARATOR
Intervention: Fluconazole (SDD isolates)
Number of subjects: 283

Group type: COMPARATOR
Intervention: Candida albicans and non-albicans Candida species
Number of subjects: 283
Study: 19841335

Group type: EXPERIMENTAL
Intervention: 3-day course of amoxicillin
Number of subjects: 49

Group type: COMPARATOR
Intervention: 7-day course of amoxicillin
Number of subjects: 49
Study: 16962481

Group type: EXPERIMENTAL
Intervention: Topical anesthetic with EMLA (eutectic mixture of lidocaine and prilocaine)
Number of subjects: 225

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 225
Study: 15513256

Group type: EXPERIMENTAL
Intervention: Multiplication facts retrieval in a number-matching task without arithmetic context.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Manipulation of spatial relation between cue digits.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Contextual definition of automaticity applied to multiplication facts retrieval.
Number of subjects: 0
Study: 11345650

Group type: EXPERIMENTAL
Intervention: Amsalog 200 mg/m2 per day for 5 days
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Amsalog 180 mg/m2 per day for 5 days
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Amsalog administered via peripheral venous line
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Amsalog
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Pharmacokinetic studies
Number of subjects: 19
Study: 9574945

Group type: EXPERIMENTAL
Intervention: 0.12% chlorhexidine gluconate mouthrinse
Number of subjects: 279

Group type: COMPARATOR
Intervention: Placebo mouthrinse
Number of subjects: 279

Group type: EXPERIMENTAL
Intervention: Oral contraceptives (in female subjects)
Number of subjects: 279

Group type: COMPARATOR
Intervention: Nonuse of oral contraceptives (in female subjects)
Number of subjects: 279

Group type: EXPERIMENTAL
Intervention: Smoking
Number of subjects: 279
Study: 7826781

Group type: EXPERIMENTAL
Intervention: Thiopentone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 0
Study: 3254133

Group type: EXPERIMENTAL
Intervention: EEG monitoring during carotid endarterectomy
Number of subjects: 131

Group type: COMPARATOR
Intervention: No EEG monitoring during carotid endarterectomy
Number of subjects: 131

Group type: EXPERIMENTAL
Intervention: No shunting with ICBP < 50 mmHg and no EEG change
Number of subjects: 131

Group type: EXPERIMENTAL
Intervention: Low ICBP with EEG change
Number of subjects: 131

Group type: EXPERIMENTAL
Intervention: Low ICBP without EEG change
Number of subjects: 131
Study: 29788981

Group type: EXPERIMENTAL
Intervention: Pazopanib 800 mg once daily
Number of subjects: 1066

Group type: COMPARATOR
Intervention: Sunitinib 50 mg once daily (in 6-week cycles: 4 weeks on, 2 weeks off)
Number of subjects: 1066
Study: 29231405

Group type: EXPERIMENTAL
Intervention: Herb-partition moxibustion and acupuncture
Number of subjects: 102

Group type: COMPARATOR
Intervention: Bran-partition moxibustion and shallow acupuncture
Number of subjects: 102
Study: 24785592

Group type: EXPERIMENTAL
Intervention: Training on Task 1 (red/green signal discrimination)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Diffusion modeling analysis
Number of subjects: 0
Study: 23942259

Group type: EXPERIMENTAL
Intervention: Mindfulness-based cognitive therapy (MBCT)
Number of subjects: 125

Group type: COMPARATOR
Intervention: Enhanced usual care (EUC)
Number of subjects: 125
Study: 20129336

Group type: EXPERIMENTAL
Intervention: Third-generation thermal uterine balloon therapy system with postprocedure curettage
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: Third-generation thermal uterine balloon therapy system without postprocedure curettage
Number of subjects: 250

Group type: COMPARATOR
Intervention: First-generation thermal uterine balloon therapy system (historic control)
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: Third-generation thermal uterine balloon therapy system (compared to first-generation)
Number of subjects: 250
Study: 18438129

Group type: EXPERIMENTAL
Intervention: Ophthalmology - Retinal reattachment surgery
Number of subjects: 921

Group type: EXPERIMENTAL
Intervention: Orthopaedics - Total hip replacement
Number of subjects: 921

Group type: EXPERIMENTAL
Intervention: General Surgery - Hernia repair
Number of subjects: 921
Study: 16619231

Group type: EXPERIMENTAL
Intervention: Lower dose: 1.1 x 10(11) platelets/m(2)
Number of subjects: 1350

Group type: EXPERIMENTAL
Intervention: Medium dose: 2.2 x 10(11) platelets/m(2)
Number of subjects: 1350

Group type: EXPERIMENTAL
Intervention: Higher dose: 4.4 x 10(11) platelets/m(2)
Number of subjects: 1350
Study: 12047429

Group type: EXPERIMENTAL
Intervention: Prophylactic group (dust mite impermeable mattress covers and advice on environmental measures)
Number of subjects: 242

Group type: COMPARATOR
Intervention: Control group (non-specific advice)
Number of subjects: 242
Study: 9672054

Group type: EXPERIMENTAL
Intervention: Risperidone (mean daily dose 2.9 mg, SD 1.4)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Risperidone
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Open-label risperidone
Number of subjects: 31
Study: 8006274

Group type: EXPERIMENTAL
Intervention: Active nitroglycerin patch therapy (0.4 mg/h, 12 h on/off)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 2690923

Group type: EXPERIMENTAL
Intervention: CHOP (COP + doxorubicin)
Number of subjects: 70

Group type: COMPARATOR
Intervention: COP
Number of subjects: 70
Study: 134670

Group type: EXPERIMENTAL
Intervention: Clindamycin
Number of subjects: 83

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 83
Study: 30227731

Group type: EXPERIMENTAL
Intervention: Paracetamol
Number of subjects: 110

Group type: COMPARATOR
Intervention: Ibuprofen
Number of subjects: 110
Study: 30720543

Group type: EXPERIMENTAL
Intervention: Single exposure to general anesthesia lasting less than 1 hour
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Multiple exposures to general anesthesia
Number of subjects: 0
Study: 28368340

Group type: EXPERIMENTAL
Intervention: High-fat breakfast
Number of subjects: 30

Group type: COMPARATOR
Intervention: Low-fat breakfast
Number of subjects: 30
Study: 24219251

Group type: EXPERIMENTAL
Intervention: Macintosh laryngoscope
Number of subjects: 70

Group type: COMPARATOR
Intervention: GlideScope
Number of subjects: 70
Study: 21895949

Group type: EXPERIMENTAL
Intervention: LigaSure
Number of subjects: 140

Group type: COMPARATOR
Intervention: Conventional bipolar instruments
Number of subjects: 140
Study: 19294323

Group type: EXPERIMENTAL
Intervention: Immediate advice (intervention group)
Number of subjects: 344

Group type: COMPARATOR
Intervention: Advice after 6 months (control group)
Number of subjects: 344
Study: 16781793

Group type: EXPERIMENTAL
Intervention: Pioglitazone (30 mg)
Number of subjects: 18
Study: 15856859

Group type: EXPERIMENTAL
Intervention: Manidipine
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Lercanidipine
Number of subjects: 53

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 53
Study: 11553256

Group type: EXPERIMENTAL
Intervention: Remifentanil 2 microg kg(‐1) followed by 0.4 microg kg(‐1) min(‐1)
Number of subjects: 286

Group type: EXPERIMENTAL
Intervention: Remifentanil 1 microg kg(‐1) followed by 0.2 microg kg(‐1) min(‐1)
Number of subjects: 286

Group type: EXPERIMENTAL
Intervention: Both remifentanil groups
Number of subjects: 286

Group type: EXPERIMENTAL
Intervention: Remifentanil infusion at 0.1 microg kg(‐1) min(‐1)
Number of subjects: 286

Group type: COMPARATOR
Intervention: Fentanyl 3 microg kg(‐1)
Number of subjects: 286
Study: 9732187

Group type: EXPERIMENTAL
Intervention: Sustained release (SR) alfuzosin (5 mg twice daily)
Number of subjects: 1051

Group type: EXPERIMENTAL
Intervention: Combination of SR alfuzosin and finasteride (5 mg once daily)
Number of subjects: 1051

Group type: COMPARATOR
Intervention: Finasteride (5 mg once daily)
Number of subjects: 1051
Study: 8299319

Group type: EXPERIMENTAL
Intervention: 300 micrograms clonidine per day
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 200 micrograms clonidine per day
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 100 micrograms clonidine per day
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 2191978

Group type: EXPERIMENTAL
Intervention: Captopril (25 mg)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Furosemide (20 mg) with captopril
Number of subjects: 8

Group type: COMPARATOR
Intervention: Furosemide (20 mg) alone
Number of subjects: 8
Study: 1093503

Group type: EXPERIMENTAL
Intervention: High-dose cyclophosphamide for six months
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Low-dose cyclophosphamide plus prednisone for six months
Number of subjects: 19

Group type: COMPARATOR
Intervention: Prednisone plus placebo for six months
Number of subjects: 19
Study: 31248392

Group type: EXPERIMENTAL
Intervention: IMPower (girls' intervention)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Source of Strength (boys' intervention)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Life skills standard of care intervention
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: IMPower and Source of Strength interventions
Number of subjects: 0
Study: 28724883

Group type: EXPERIMENTAL
Intervention: Calcium carbonate (1000 mg) 3 times a day for 3 days
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 25464934

Group type: EXPERIMENTAL
Intervention: Venlafaxine
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Applied Relaxation
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Combination Treatment (for non-remitted patients)
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Both Treatments
Number of subjects: 58
Study: 23768206

Group type: EXPERIMENTAL
Intervention: Inhaled corticosteroids (ICS)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (children whose asthma is controlled by ICS)
Number of subjects: 0
Study: 21665167

Group type: EXPERIMENTAL
Intervention: Knee Injury and Osteoarthritis Outcome Score (KOOS)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: 6-minute walk (6MW)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Timed-up-and-go (TUG)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Stair climbing tests (SCT)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Quadriceps strength
Number of subjects: 39
Study: 20183467

Group type: EXPERIMENTAL
Intervention: Targeted maximum likelihood methodology
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Substitution‐based approach
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Direct targeting of the logrank parameter
Number of subjects: 0
Study: 16669830

Group type: EXPERIMENTAL
Intervention: Emergency physicians' ECG interpretation
Number of subjects: 133

Group type: EXPERIMENTAL
Intervention: Likelihood classification by emergency physicians
Number of subjects: 133
Study: 16642612

Group type: EXPERIMENTAL
Intervention: Acupoint catgut embedding therapy at Dachangshu (BL 25), Zusanli (ST 36), Shangjuxu (ST 37)
Number of subjects: 116

Group type: COMPARATOR
Intervention: Oral administration of salicylazosulfapyridine, 4-6 g/day
Number of subjects: 116
Study: 14658949

Group type: EXPERIMENTAL
Intervention: Risperidone 6 mg/day
Number of subjects: 49

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 49
Study: 10073740

Group type: EXPERIMENTAL
Intervention: GI198745 (dutasteride) 0.01 to 40 mg single oral doses
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: GI198745 (dutasteride) 0.1 mg daily doses
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: GI198745 (dutasteride) above 1 mg daily doses
Number of subjects: 32
Study: 7589382

Group type: EXPERIMENTAL
Intervention: 2.5 mg rhDNase twice daily for 14 days
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: 2.5 mg rhDNase twice daily during the OEP
Number of subjects: 70

Group type: COMPARATOR
Intervention: Placebo for 14 days
Number of subjects: 70
Study: 2187377

Group type: EXPERIMENTAL
Intervention: Spinal anesthesia with ketamine sedation (group 2 A)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Spinal anesthesia without ketamine sedation (group 2 B)
Number of subjects: 36

Group type: COMPARATOR
Intervention: General anesthesia
Number of subjects: 36
Study: 389103

Group type: EXPERIMENTAL
Intervention: Theophylline (200 mg capsules, Elixophyllin)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Theophylline
Number of subjects: 12
Study: 31506739

Group type: EXPERIMENTAL
Intervention: Stepped care
Number of subjects: 1012

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 1012
Study: 27792020

Group type: EXPERIMENTAL
Intervention: Sitting boxing program + conventional physical therapy (3 times/week for 6 weeks)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Conventional physical therapy (3 times/week for 6 weeks)
Number of subjects: 26
Study: 25735561

Group type: EXPERIMENTAL
Intervention: Organised collagen in tumor-associated stroma
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Stromal organization
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Stromal organization determined on H&E-stained and AZAN-stained tissue sections
Number of subjects: 0